Prostate Cancer: Advances in Genetic Testing and Clinical Implications

The demand for genetic testing (GT) prostate cancer (PCa) is expanding, but there limited knowledge about the counseling (GC) needs of men. A strong-to-moderate inherited predisposition causes approximately 5–20% (PCa). In men with cancer, germline may benefit patient by informing treatment options, and if a mutation noticed, it also guide screening other cancers have family implications cascade (testing close relatives same mutation). Relatives mutations be eligible early detection strategies preventive measures. Cascade can favorable members, currently unutilized, to overcome obstacles like deficiency, communication, lack access services, expenses are needed. this review, we will look at factors that been linked as well role in advanced cancer.